Document Detail


The epithelial sodium channel in hypertension: genetic heterogeneity and implications for treatment with amiloride.
MedLine Citation:
PMID:  15174897     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The epithelial sodium channel (ENaC) has a central role in sodium transport across membranes. It is expressed on the apical cell surface of renal tubular epithelia and also on other aldosterone-responsive epithelial cells. In the kidney, ENaC contributes to the regulation of blood pressure via changes in sodium balance and blood volume. Rare monogenetic disorders associated with hypertension have been described, such as Liddle syndrome, which gives rise to increased sodium reabsorption in the kidney via increased ENaC activity. There are many other variants in the genes encoding ENaC subunits, some of which occur with sufficient frequency as to be termed polymorphic variants. The Thr594Met polymorphism of the ENaC beta-subunit gene SCNN1B occurs exclusively in Black individuals, with a frequency of 6-8% in those with hypertension. It increases cAMP mediated ENaC sodium current in affected B lymphocytes, and has been associated with hypertension in a Black South London population. There is preliminary evidence that amiloride is effective as monotherapy in hypertensive individuals with the Thr594Met polymorphism and in patients with resistant hypertension, who have evidence of increased amiloride-sensitive sodium channel activity. If these preliminary studies are corroborated in larger studies, then amiloride may provide an important new strategy for blood pressure control in selected individuals.
Authors:
Pauline A Swift; Graham A MacGregor
Related Documents :
3337097 - The effect of red cell transfusion on hemodialysis-related hypotension.
7124947 - Sodium transport in the rabbit connecting tubule.
3142907 - Potassium: weighing the evidence for supplementation.
14974027 - Advice to reduce dietary salt for prevention of cardiovascular disease.
20076127 - Pressure dependence of the infrared-active phonons in the mixed crystal system kcl(1-x)...
23094157 - Renal function in patients with hypertension associated congestive cardiac failure seen...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  American journal of pharmacogenomics : genomics-related research in drug development and clinical practice     Volume:  4     ISSN:  1175-2203     ISO Abbreviation:  Am J Pharmacogenomics     Publication Date:  2004  
Date Detail:
Created Date:  2004-06-03     Completed Date:  2004-09-16     Revised Date:  2009-11-03    
Medline Journal Info:
Nlm Unique ID:  100967746     Medline TA:  Am J Pharmacogenomics     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  161-8     Citation Subset:  IM    
Affiliation:
Blood Pressure Unit, St George's Hospital Medical School, London, UK. pswift@sghms.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amiloride / therapeutic use*
Animals
Diuretics / therapeutic use*
Epithelium / drug effects,  physiology*
Humans
Hypertension / drug therapy*,  genetics*
Polymorphism, Genetic
Sodium Channels / drug effects,  genetics*,  physiology*
Chemical
Reg. No./Substance:
0/Diuretics; 0/Sodium Channels; 2609-46-3/Amiloride

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacogenetics of antihypertensive drug responses.
Next Document:  Genome-scale analysis of lung cancer progression.